Rusfertide (for HCT Control)- FDA status - MPN Voice

MPN Voice

10,834 members15,131 posts

Rusfertide (for HCT Control)- FDA status

EPguy profile image
10 Replies

I came across this info today.

Mar 28 2024: "Protagonist Therapeutics said it plans to seek FDA approval for rusfertide for treating polycythemia vera in late 2025"

cancer.gov/news-events/canc...

and an explanation why it has taken so long, an FDA hold a few years ago:

Oct 2021 "The FDA has removed the full clinical hold that had previously been placed on trials evaluating rusfertide (PTG-300)"

They were monitoring mice on it and "found benign and malignant subcutaneous skin tumors" Seems ok in humans since trial resumed, but no doubt they are watching carefully. Sometimes they use very high doses in these sort of non-clinical studies, but it's not specified.

--

One application for Rusf may be HCT resistance on IFN, a problem we're seeing regularly on the forum.

Written by
EPguy profile image
EPguy
To view profiles and participate in discussions please or .
Read more about...
10 Replies
Lena70 profile image
Lena70

Very exciting news.

hunter5582 profile image
hunter5582

Good news!

saltmarsh profile image
saltmarsh

Thanks for the update. Definitely good news

Lyndjs profile image
Lyndjs

Thank you for sharing and update.

Lx

ritaandscooter1 profile image
ritaandscooter1

Good news! My Mayo MPN recommended this for iron deficient, phlebotomy dependent people like myself. Will also help keep HCT stable. He said the only draw back is the injection site gets extremely irritated and must have injection every week. He said there is a better drug in the works (Disc) that he is hoping to put me in the clinical trial in the fall. Basically does the same thing but much less side effects. He highly recommends this one heading for clinical trials.

EPguy profile image
EPguy in reply toritaandscooter1

Good to know on the irritation. Sounds like the pt quickly runs out of fresh injection sites.

On the new one I think you refer to MWTX-003:

ir.discmedicine.com/news-re...

It's in trial for MF right now, interesting that it can help reduce both MF anemia and PV HCT. Part of the complex interactions going on.

clinicaltrials.gov/study/NC...

ritaandscooter1 profile image
ritaandscooter1 in reply toEPguy

I think there is a new Disc drug trial coming out in the fall which may be different than the above links you sent?? Not entirely sure how different they are. Iron retention is involved with both. Will find out when I see the doc next time.

EPguy profile image
EPguy in reply toritaandscooter1

Agree, the new trial would be for PV, while the current one is for MF.

ritaandscooter1 profile image
ritaandscooter1 in reply toEPguy

Thanks for this info! I'm so happy they are coming out with drugs to improve ones QOL especially due to iron deficiency.

EPguy profile image
EPguy in reply toritaandscooter1

I've come to appreciate how lucky we've been to have the treatments we have. having a condition with none. Every step makes someone's life better.

Not what you're looking for?

You may also like...

FDA Rejects Ropeginterferon alfa-2b for Polycythemia Vera

« The drug development process is not always easy or quick. It consists of drug discovery,...
Manouche profile image

FDA Issues Complete Response Letter for Ropeginterferon Alfa-2b for Polycythemia Vera

« The FDA has issued a complete response letter regarding the biologics license application for...
Manouche profile image

FDA Approves Ropeginterferon Alfa-2b-njft for Polycythemia Vera

The FDA has approved ropeginterferon alfa-2b-njft (Besremi) for use as a treatment in patients...
JT_Marlin profile image

Updated Phase 2 Data Supporting Long-Term Efficacy of Rusfertide in Polycythemia Vera

Summary of Results: Therapeutic phlebotomies were essentially eliminated and a target hematocrit...
Manouche profile image

Clinical Trail Updates for Patients

This is a different webinar that the one by Dr. Mesa on March 30. From our friends at MPN Advocacy...
hunter5582 profile image